Upgrade to SI Premium - Free Trial

Barclays on Eli Lilly (LLY): Centessa a 'sensible tuck-in' for neuroscience division

March 31, 2026 12:30 PM
Barclays analyst Emily Field reiterated an Overweight rating and $1,350.00 price target on Eli Lilly (NYSE: LLY)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments